Centers For Medicare And Medicaid

Five things for pharma marketers to know: Tuesday, January 12, 2016

Five things for pharma marketers to know: Tuesday, January 12, 2016

By

HCPs sound off on CMS opioid proposal; Senate committee to decide if Califf gets FDA commissioner nod; Celgene names new CEO

Five things for pharma marketers to know: Tuesday, May 5

Five things for pharma marketers to know: Tuesday, May 5

By

Worldwide spending on cancer medications hit $100 billion last year; Bayer adds an anticoagulant to its pipeline for $100 million; GlaxoSmithKline has a new chairman

Open Payments glitches limit submissions

Open Payments glitches limit submissions

By

The CMS said the issues should be resolved this week and will not affect this month's deadline for companies to submit payment data from 2014.

2013 healthcare spending crept upwards

2013 healthcare spending crept upwards

By

Centers for Medicare and Medicaid Services says it is too early to blame a sluggish economy for slow growth.

Five things for pharma marketers to know: Thursday, November 20

Five things for pharma marketers to know: Thursday, November 20

By

CRS asks if high prices are a tool to offset CMS rebates, the FDA adds another DTC study to its lineup, and the NIH proposes making more clinical trial data public.

Medicare to cover some hep. C screening

Patients have to be high-risk or Baby Boomers for coverage.

CMS lax in EHR-enabled fraud, OIG says

CMS lax in EHR-enabled fraud, OIG says

By

CMS could provide more guidance for how to crack down on healthcare fraud, the OIG asserts in a report.

Patent cliff a drag on 2012 health spend

Patent cliff a drag on 2012 health spend

By

Generics accounted for almost 75% of dispensed drugs in 2012, according to CMS researchers.

Antidepressants may have to fight for Part D coverage

CMS is proposing a rule that could change how antidepressants get on Medicare Part D formularies.

CMS rolls out researcher tool

The tool lets researchers tap into health data from work, meaning the year-long waits for data are over.

ACA enrollment misses target

Official numbers are pending, but Reuters notes enrollment appears to be just 3% of the government's goal.

CMS projects healthcare spending to rise

CMS projects healthcare spending to rise

By

Researchers says growth will average 5.8% a year between 2012 and 2022. They also anticipate generics will hit a leveling-off point that will drive average Rx prices upwards

Good day, Sunshine: Tools help docs track payments

Good day, Sunshine: Tools help docs track payments

By

With a new era of transparency for doctors and life science manufacturers kicking off today, here's how some organizations are keeping physicians informed.

Industry pushing for further clarity on Sunshine Act

Industry pushing for further clarity on Sunshine Act

By

With a clear buffet exemption in-hand, the agency's position with respect to CME meals seems pretty clear. Industry is pushing for more clarity around the treatment of accrediting bodies.

Lilly Alzheimer's tracer fails to win CMS support

Lilly Alzheimer's tracer fails to win CMS support

By

The drug maker asked CMS to approve its Amyvid PET tracer for Medicare beneficiaries, but CMS declined, saying in a draft decision that widespread use would be of little value.

For Obama's head-less CMS, third time's the charm

For Obama's head-less CMS, third time's the charm

By

Acting administrator Marilyn Tavenner seems on track for confirmation, with the blessings of all industry stakeholders

CMS warms to some stakeholders, burns others with Sunshine rule

By

Clinical Research Organizations, marketing research firms, accredited CME providers and lawyers look to be the big winners in CMS's Sunshine Act rule.

Researchers find schools minting pitch-resistant docs

By

A BMJ study finds that medical school gift bans make doctors less likely to prescribe a new drug. Also of note: consumers think money motivates some doctors' recommendations.

Opinion

How to Shatter the Glass Ceiling

How Pharma Can Benefit from the Transformation of Pharmacy

Newsletters

Live at MM&M Transforming Healthcare

Pharma faces its 'oh, shit' moment

In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.

Merck, Takeda execs: Is AI the new bad app?

One executive referred to AI as a "black box" and as the "Tower of Babel."

Value-based care requires innovators to challenge the status quo

Execs stressed the importance of collaboration, consumer-mindedness.

Admetsys wins the 2017 MM&M Startup Showdown

The artificial pancreas can provide value to the health system.

Top 40 Healthcare Transformers

MM&M honors 40 upstarts and veteran innovation gurus.

Top 10 Innovation Catalysts

For the first time MM&M honors a group of 10 agency execs.